ArticlePDF Available

Serum glucose and insulin response to mango and papaya in type 2 diabetic subjects

Authors:
  • Pothikrit Institute of Health Studies (PIHS)

Abstract

To rank Bangladeshi Mango and Papaya in terms of their Glycemic Index (GI) and Insulinemic Index (II), which are useful measures of glucose and insulin responses to a dietary component, thirteen type 2 diabetic subjects consumed, under a cross-over design, equi-carbohydrate amounts of mango (250 g), papaya (602 g) and white bread (the reference food, 63 g). Blood sample was drawn 5 times between 0h and 3h. Serum C-peptide was measured to evaluate Insulinemic status. Mango and Papaya showed higher serum glucose responses compared to that of bread. The similar glycemic responses of Papaya and Mango were reflected in their GI values. Papaya showed higher insulin response compared to both Mango and Bread (p < 0.001). Papaya also showed significantly higher C-peptide–glucose ratio in comparison to that of Mango and Bread. The data suggest that equi-carbohydrate amount of Papaya and Mango produce higher glycemic response as compared to bread, but the two fruits are comparable regarding this property. The higher insulin response of papaya needs to be considered in case of therapeutic management of diabetic patients and in assessing the risk of atherogenesis due to hyperinsulinemia.
Serum glucose and insulin response to mango and papaya
in type 2 diabetic subjects
Kaniz Fatema, MSc, Liaquat Ali, PhD*, Mohammad H Rahman, MSc,
Shahana Parvin, MBBS, MPhil, Zahid Hassan, MBBS
Biomedical Research Group, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and
Metabolic Disorders (BIRDEM), Dhaka—1000, Bangladesh
Received 30 July 2002; received in revised form 16 September 2002; accepted 20 September 2002
Abstract
To rank Bangladeshi Mango and Papaya in terms of their Glycemic Index (GI) and Insulinemic
Index (II), which are useful measures of glucose and insulin responses to a dietary component, thirteen
type 2 diabetic subjects consumed, under a cross-over design, equi-carbohydrate amounts of mango
(250 g), papaya (602 g) and white bread (the reference food, 63 g). Blood sample was drawn 5 times
between 0h and 3h. Serum C-peptide was measured to evaluate Insulinemic status. Mango and Papaya
showed higher serum glucose responses compared to that of bread. The similar glycemic responses of
Papaya and Mango were reflected in their GI values. Papaya showed higher insulin response compared
to both Mango and Bread (p0.001). Papaya also showed significantly higher C-peptide–glucose
ratio in comparison to that of Mango and Bread. The data suggest that equi-carbohydrate amount of
Papaya and Mango produce higher glycemic response as compared to bread, but the two fruits are
comparable regarding this property. The higher insulin response of papaya needs to be considered in
case of therapeutic management of diabetic patients and in assessing the risk of atherogenesis due to
hyperinsulinemia. © 2003 Elsevier Science Inc. All rights reserved.
Keywords: Diabetes Mellitus; Glycemic Index; Insulinemic Index; Mango; Papaya; Dietary management
1. Introduction
A debate is going on for centuries regarding the amount of carbohydrate that individuals
with diabetes should consume. The latest consensus is towards liberalization of carbohydrate
* Corresponding author. Tel.: 880-2-8613700, 8617130; fax: 880-2-8613004; 8617130.
E-mail address: lali@dab-bd.org (L. Ali).
www.elsevier.com/locate/nutres
Nutrition Research 23 (2003) 9–14
0271-5317/03/$ – see front matter © 2003 Elsevier Science Inc. All rights reserved.
PII: S0271-5317(02)00492-X
intake with 50% to 60% of the total calories in the diet for this source [1]. Special caution,
however, is required to dene the nature of carbohydrate due to the central importance of
maintaining normoglycemia and due to the need for adjustment of drug regimens in
consideration of a particular diet.
Carbohydrate content varies from one food to another. So, a method of ranking the
carbohydrate containing food has been proposed on the basis of the incremental blood
glucose responses, glycemic index (GI), produced for a given amount of food [2]. Glucose,
in turn, triggers insulin secretion from the pancreatic beta cells. So, in addition to GI, the
amount of insulin secreted in response to food is also important in the management of
diabetes and its vascular complications. Since insulin is now known to be atherogenic, a low
GI at the expense of hyperinsulinemia may not always be useful. Thus ranking of food based
on their insulinemic response, along with the glycemic response, is necessary. Measurement
of Insulinemic index (II) and C-peptide-glucose ratio may be two indicators of this response.
Due to the problem in differentiating endogenous and exogenous insulin, measurement of
C-peptide is preferred as a measure of serum insulin. Thus C-peptide Index and C-peptide-
glucose ratio are equated with insulin Index and insulin-glucose ratio.
Fruits form a major part of daily diet in both in healthy and diseased people and those have
a variety of pleasant and attractive avors. It has also laxative and base forming properties
inspite of equivalent different amount of carbohydrate [3]. To prepare a diet plan for diabetic
and cardiovascular patients in the local perspective we need to grade these foods according
to their glycemic and insulinemic responses. However, no attempt has so far been made in
this direction for Bangladeshi foods. Very recently our group has undertaken a long-term
program to assess the GI and II of common dietary components of Bangladesh. The present
work is the rst one to investigate the fruits in this country under the series. Langra Mango
(Mangifira Indica L) and Papaya (Carica Papaya L), being two of the most popular and
available fruits in the country, have been chosen for this study.
2. Methods and materials
2.1. Subjects
Thirteen (13) Type 2 diabetic subjects (male 7 and female 6) were included in this study.
The participants were selected from the BIRDEM Outpatient Department. Diabetes was
diagnosed and classied by the WHO criteria [4]. Patients with acute or chronic complica-
tions of diabetes mellitus and those using insulin, oral contraceptives or steroid were
excluded. Pregnancy was also an exclusion criteria. All participants gave their written
consent after being fully informed about the nature of the study.
2.2. Study design
Detailed family history was taken, and clinical and biochemical ndings were recorded in
a predesigned case record form. The body weight, in kilogram, was measured by using
appropriate scales (Detect-Medic, Detect Scales INC, USA). Body Mass Index and waist-hip
10 K. Fatema et al. / Nutrition Research 23 (2003) 9–14
ratio of the subjects were calculated by appropriate formula. The subjects were requested to
fast overnight (8-10 hr) and suggested not to take medicine. An intravenous cannula was
inserted into a supercial vein in the forearm, fasting blood samples were collected and meal
was served. The meal was consumed within 15 min along with 200 ml water. Blood samples
were then collected at 30, 60, 120 and 180 minutes. Separated serum was preserved at
40°C for future biochemical analysis.
2.3. Test meals
Langra Mango (Mangira Indica L) (250 g) and Papaya (Carica Papaya L) (602 g),
having 50 g available carbohydrate in each fruit (calculated from a food table) [5], were
given to the subjects. White bread (63 g calculated by chemical analysis) was given as a
reference meal.
2.4. Laboratory method
Serum glucose was measured by glucose-oxidase method (Sera Pak, Bayer, USA),
C-peptide was measured by an ELISA technique (DRG International Inc, Germany) and
Fructosamine was measured by colorimetric method (Boaheringer-Mannheim, Germany).
2.5. Statistical analysis
All analyses were done using the SPSS Windows Package. Experimental values were
expressed as mean SD (standard deviation) or median (range) as appropriate. To compare
results between two groups students t-test were performed where appropriate. ANOVA
(Duncan) was performed to test the difference between means and Nonparametric (Mann-
Whitney) test was done to calculate the difference of different test meals and Bonferroni t
test for ratio of different parameters. Integrated serum glucose values over the 3 hour time
period was calculated by area under the curve using a mathematical model [6].
3. Results
The study was conducted on non-obese subjects (BMI 24.57 2.53 and waist-hip ratio
1.07 0.01, M SD) with mild to moderate hyperglycemia (serum fructosamine 391 93,
mol/l, M SD) (Table I). The absolute value of serum glucose in fasting as well as in
postprandial states showed no signicant difference among the Bread, Papaya and Mango
groups. The integrated serum value during the 3-hour time period also showed no difference
(Table II). Glycemic Index (GI) of Papaya (124 14; M SD) was close to that of Mango
(122 10, Table II). Fasting serum C-peptide (ng/ml, M SD) levels in cases of Bread,
Papaya and Mango did not differ among themselves. The respective 3-hour postprandial
serum C-peptide levels after feeding Bread, Papaya and Mango were as follows: 3.99 1.39,
5.54 1.67 and 4.15 1.70 respectively (p 0.01 in Papaya vs Bread; and p 0.003 in
Papaya vs Mango, Table III). Absolute increment of C-peptide values [median (range),
11K. Fatema et al. / Nutrition Research 23 (2003) 914
ng/ml] was calculated in response to three test meals. Secretory response to Mango 1.05
(0.21-3.95) was signicantly low compared to both Bread 2.73 (0.65-5.0) and Papaya 2.72
(0.65-5.0) (Table III). Fasting C-peptide-Glucose ratio of Bread (0.34 0.16) showed lower
value compared to Papaya (0.44 0.21) but the difference did not reach level of signicance
(p 0.058). Postprandial C-peptide-glucose ratio of Papaya was signicantly higher com-
pared to Bread (p 0.01) and Mango (p 0.003). C-peptide Index (CI) of Papaya (129
33) did not show statistically signicant difference compared to mango (112 45, t
1.746, p 0.106).
4. Discussion
Fruits can be excellent components of the diet in diabetic patients. This is for their high
nutritional values (particularly in respect of micronutrients) and for their palatability which
increases patient compliance. However, starchy and juicy fruits are generally avoided by
diabetic patients and those are advised by the physicians and dieticians with substantial
restriction. To rationalize the advice of fruits in diabetic (as well as cardiovascular) patients,
it is important to know their chemical composition and above all their biological responses.
The substitution of calories and other nutrients may then be done on the basis of patient
choice, socioeconomic capability and availability of fruits.
Glycemic Index (GI) is useful in monitoring the biological response of a food in relation
to glycemic status. The present study evaluates the GI of Mango and Papaya in type 2
Table I
Clinical and sociodemographic characteristics of the study subjects
Parameters Values
Age (years, mean SD) 39.46 6.21
BMI (mean SD) 24.57 2.53
Waist-hip ratio (mean SD) 1.07 0.01
Male : Female 27:23
Rural : Urban 4:9
Annual income (median-range) in US Dollars 2316 (10504210)
Serum fructosamine (mean SD,
mol/l) 391 93
Table II
Effect on glycemic status of the study subjects (n 13) after feeding the different test meals
Test
foods Serum glucose (mmol/l) AUC (mmol/
l/ 180 min) Glycemic
Index
0 min 30 min 60 min 120 min 180 min
Bread 8.7 3.5 9.8 2.8 10.9 2.5 9.8 2.5 8.3 2.7 1745 450
Papaya 9.2 3.4 13.0 3.1 14.3 3.0 11.6 3.5 9.5 3.4 2138 639 124 14
Mango 9.7 3.2 13.4 3.3 13.7 3.5 11.2 4.1 9.8 3.5 2153 566 122 10
Results expressed as mean SD; ANOVA (Duncan) test was performed to test the difference between means.
p0.05 was taken as the level of signicance; n, Number of subjects; AUC, Area under the curve.
12 K. Fatema et al. / Nutrition Research 23 (2003) 914
diabetic subjects. In line with the popular impression, the results suggest that, Mango and
Papaya produces higher glycemic response compared to Bread (the reference diet) (Table II
& III). These properties of Papaya and Mango need to be considered when dietary advice is
given. It is interesting to note that Mango and Papaya have equivalent GI. It means that, on
calculating the exact calorie requirement, the dietician may freely criss-cross Papaya and
Mango so far as the blood glucose level is concerned. This fact may provide substantial
exibility to the clinicians and dieticians regarding the advice on foods and it may improve
the satisfaction of the patients and increase their compliance.
Insulin is the central hormone in maintaining blood glucose homeostasis. In type 2
diabetes mellitus the absolute level of insulin may be low, normal or higher in the blood
although there is always a relative insulin deciency. In spite of the life-saving role of the
hormone the level of higher insulin in blood (hyperinsulinaemia) has been shown to be
associated with increased atherosclerosis leading to cardiovascular disorders [7]. Due to this
atherogenic role of insulin it is desirable to control the blood glucose of patients keeping the
insulin levels as low as possible. In this context, serum C-peptide (a marker of insulin)
measurement in the present study has an important implications. The results show that
although GI is same for Papaya and Mango, the insulin response is substantially higher
[reaching signicant levels in case of absolute values (Table II) and C-peptide Index (Table
III)] in case of papaya. This insulin secretogogue property may have some advantages in
cases of patients with low insulin levels, but in patients with normal or higher insulin levels
this may not be desirable. In the absence of detailed biochemical investigations for insulin
secretory capacity (or at least for insulin/C-peptide level measurements) it is difcult to
assess the Insulinemic status of a subject. In these circumstances it seems that a cautious
approach is necessary regarding the quantity of papaya advised. The physicians should also
be aware of this property of papaya when an oral drug or insulin is prescribed. If a free choice
is given, mango should be the preferred food for a diabetic patient whose insulin secretory
status is unknown.
The Mango investigated in this study is Langra and the Papaya was only of one variety.
It is now necessary to study other common varieties of mango and papaya. Study should also
be undertaken to explore the mechanism of papaya induced increase in serum insulin levels
of the patients.
Table III
Fasting and postprandial serum insulinemic response, insulinemic index and c-peptide : glucose ratio of the
study subjects (n 13) after feeding the different test meals
Test
foods Serum C-peptide (ng/ml) AICP (ng/ml) Insulinemic
Index C-peptide : Glucose ratio
0 min 180 min 0 min 180 min
Bread 2.67 1.04 3.99 1.39
a
2.73 (0.655.0)
a
0.34 0.16 0.44 0.21
a
Papaya 2.86 0.94 5.45 1.67
b
2.72 (0.655.0)
a
129 33 0.44 0.21 0.52 0.25
b
Mango 2.92 1.10 4.15 1.70
a
1.05 (0.213.95)
b
112 45 0.31 0.14 0.39 0.21
a
Results expressed as mean SD or median (range); Paired students t, Bonferroni tand nonparametric
(Mann-Whitney) test were performed where appropriate to calculate statistical difference between groups.
Different superscripts in each column indicate signicant statistical difference at p 0.05. AICP, Absolute
increment of C-peptide over basal values.
13K. Fatema et al. / Nutrition Research 23 (2003) 914
Acknowledgments
Thanks are due to the participants in the study. We are grateful to Diabetic Association of
Bangladesh (DAB), ENRECA Project of Danish International Development Assistance
(DANIDA) and International Program in the Chemical Sciences (IPICS), Uppsala Univer-
sity, Sweden, for their nancial support.
As one of the study in a series conducted by his Group LAliclosely supervised and
monitored all aspects of this study from conception of the idea to submission of the paper;
MH Rahman was involved in the biochemical analysis of serum glucose and insulin; S
Parvin took part in project design and data interpretation; Z Hassan was involved in
statistical analysis.
References
[1] Vinik A, Wing RR, Lauterio TJ. Nuritional management of the person with diabetes. In: Porte D Jr, Sherwin
RS, editors. Ellenberg & Rifkins Diabetes Mellitus. 5th ed. Stamford Connecticut: Appleton & Large, 1996.
p. 609652.
[2] Wolever TMS, Jenkins DJA, Jenkins AL, Josse KG. The glycemic index: methodology and clinical
implications. Am J Clin Nutr 1991;54:84654.
[3] Englyst HN, Kingman SM. Carbohydrate. In: Garrow JS, James WPT, editors. Human Nutrition, and
Dietetics. 9th ed. Edinburgh London: Churchill Livingstone, 1994. p. 3855.
[4] Expert Committee on the Diagnosis and Classication of Diabetes Mellitus. Report of the expert committee
on the diagnosis and classication of diabetes mellitus. Diabetes Care 1997;20:118397.
[5] Desio Khadder Pustiman. In: Sastha Rakhay Pusti. Ali SMK (editor), Bangle Printers, Dhaka. 1995. p. 314.
[6] Tai MM. A mathematical model for the determination of total area under glucose tolerance, and other
metabolic curve. Diabetes Care 1994;17:1524.
[7] Kaplan NM. Hypertension and diabetes. In: Porte D Jr, Sherwin RS, editors. Ellenberg & Rifkins Diabetes
Mellitus. 5th ed. Stamford Connecticut: Appleton & Large, 1996. p. 10971104.
14 K. Fatema et al. / Nutrition Research 23 (2003) 914
... Fruits consist mainly of carbohydrates and are known to have high nutritional values specifically in terms of micronutrients (Fatema et al., 2003). Nevertheless, the compositions vary greatly (Hoover-Plow, Savesky & Dailey, 1987). ...
... The type and amount of fruits to be included in daily diets of diabetics has always been a concern (Guevarra & Panlasigui, 2000). Fatema et al. (2003) has reported that it is important to know the composition of fruits and their biological responses in order to rationalise the advice of including fruits in the diet of diabetic patients. In addition, Brand-Miller, Olagiuri & Foster-Powell (1997) have documented that tropical fruits may produce higher responses of postprandial blood glucose than temperate fruits. ...
... Decoctions and infusions obtained from the morphological parts of Carica papayahave been used traditionally in the management of several ailments including cancer, DTN, diarrhea, in ammation and infectious diseases (51). In an early human study, there was an increase in the serum insulin levels of type 2 diabetic patients that took 602 g of C. papaya fruit; a nutritional dose that is equivalent to 50 g of carbohydrate (52). The administration of the methanol extract of C. papaya leaves to Wistar rats at a twice daily dose of 100 mg/kg bw displayed remarkable antihypertensive effect as it reduced the plasma angiotensin converting enzyme (ACE) activity and cardiac hypertrophy at levels similar to the positive control, enalapril (53). ...
Preprint
Full-text available
Background:Diabetes mellitus (DM) continues to pose a major global health threat with serious economic burden in sub-Saharan Africa, especially Nigeria. This condition is often worsened with accompanying comorbidities, further putting a strain on patient wellbeing. Medicinal plants are not only effective in DM, but some of them are also have beneficial effects on accompanying disease states. Such plants may be appropriate alternatives or adjuncts to available antidiabetic medications. This study aimed at accessing and documenting the medicinal plants used in four local government of southwestern Nigeria for the management of diabetes and its comorbidities. Methods:Semi-structured questionnaires were used to obtain information from traditional medical practitioners, village elders and herb sellers. The data obtained were analyzed and discussed in relation to previously published literature. Fifty-three respondents mostly males (77.4%) provided information on medicinal plants useful for the management of diabetes and its comorbidities. Results:A total of 77 medicinal plants belonging to 76 genera in 44 plant families were mentioned in the survey. In particular, 53 medicinal plants are mentioned for managing diabetes, 35 for hypertension, 28 for stroke, 17 for heart diseases and 25 for obesity. The most frequently cited plant family was Leguminosae (12%), followed by Euphorbiaceae (8%). The frequently used plant species includesVernonia amygdalina, Citrus aurantifolia, Viscum album, Carica papaya, Allium sativum. It is interesting to note that only Citrus aurantifoliawas mentioned severally for the management of the five ailments. The herbal recipes, methods of herbal preparation and administration were also recorded. Conclusions:The survey shows that a significant number ofmedicinal plants are used for the management of diabetes and its comorbidities in the study area. These plants, apart from their hypoglycemic activity, may be useful against the most common complications of DM and may provide strategies for the development of less expensive therapies especially in low income communities.
... Similarly the study conducted in thirteen type 2 diabetic subject's reports that equi-carbohydrate amount of papaya and mango produced higher glycemic response as compared to bread (reference food). The similar glycemic responses of Papaya and Mango were reflected in their glycemic index values [2]. There is evidence that IN and FOS can lower the glycemic index. ...
Article
Full-text available
... Similarly the study conducted in thirteen type 2 diabetic subject's reports that equi-carbohydrate amount of papaya and mango produced higher glycemic response as compared to bread (reference food). The similar glycemic responses of Papaya and Mango were reflected in their glycemic index values [2]. There is evidence that IN and FOS can lower the glycemic index. ...
Article
Full-text available
Papaya and banana bars were developed incorporating inulin (IN) and fructooligosaccharides (FOS) (Liquid and Powder form) in various proportions. The control bars were standardized using 70% fruit pulp, 30% sugar, 0.3% citric acid while the treated bars were standardized with 70% fruit pulp, 15% sugar, 15% of IN and FOS and 0.3% citric acid. Among the various proportions tested, papaya bars with 90% FOS (Powder) + 10% IN and banana bars with 90% FOS (liquid) + 10% IN were sensorially best accepted. The study revealed that addition of IN and FOS improved the sensory scores. The Physico-chemical and proximatecomposition analysis revealed slight changes in brix°, total sugars, reducing sugars, nonreducing sugars, moisture, protein, fat, vitamin C, ash, iron, zinc, calcium and crude fibre between control and treated fruit bars. Further the glycemic index of papaya bar was reduced from 65 to 54 when treated with FOS and IN.
... Similarly the study conducted in thirteen type 2 diabetic subject's reports that equi-carbohydrate amount of papaya and mango produced higher glycemic response as compared to bread (reference food). The similar glycemic responses of Papaya and Mango were reflected in their glycemic index values [2]. There is evidence that IN and FOS can lower the glycemic index. ...
... In addition to the mango pulp, the kernel, peel, leaves, stem and bark have all been utilized for research. Research on the different parts of mango fruit and tree have explored its antioxidant and anti-inflammatory properties, anti-bacterial, anti-viral, anti-HIV, anti-cancer, anti-diabetic, anti-atherogenic, and immune-modulatory properties as well as functions in bone health [180][181][182][183] . ...
Article
Mango has long been an attractive source of nutrition and pharmacological therapeutics. The mango plant (Mangifera indica L.) contains bioactive compounds that may have antidiabetic properties. This systematic review investigated the evidence for antidiabetic properties of the different parts of the mango plant in managing type 2 diabetes mellitus in animal models and humans. The electronic databases PubMed, FSTA, Web of Science, CINAHL, MEDLINE, and Cochrane Library were systematically searched to identify articles with clear objectives and methodologies available in the English language with publication date limits up to December 2020. Twenty-eight of 1001 animal and human studies met the inclusion criteria that investigated antidiabetic properties of mango from leaf (31%), flesh (38%), seed-kernel (7%), peel (14%), stem-bark (7%), and by-product (3%). Results support the glucose-lowering properties of mango in both animals and human. Proposed antidiabetic mechanisms of action include inhibition of α-amylase and α-glucosidase, improved antioxidant status, improved insulin sensitivity, facilitated glucose uptake, and gene regulation of glucose transporter type 4, insulin receptor substrate 1, and phosphoinositide 3-kinase. The animal and randomized control trial findings suggest that mango may be beneficial as an antidiabetic agent. Although these studies hold promise, additional observational studies and randomized control trials are required because human studies are significantly fewer in number, use mango flesh almost exclusively, and had modest blood glucose effects. Additional research gaps include identifying the mechanisms of action for the different components of the mango plant.
Article
The present study demonstrated that soybean flour (SF) (5 g L⁻¹) can sorb flavonoids from mango juice concentrate (MJC) (20 mL) while separating them from sugars. Depending SF concentration and juice dilution, the concentration of total phenolics and flavonoid sorbed to SF ranged from 13.55 mg g⁻¹ and around 0.14-2.03 mg g⁻¹ respectively. The rutin gave the highest content about 4.58 mg g⁻¹. The concentration of the MJC polyphenolic and flavonoids components was eluted from SF and remained constant after 22 weeks of incubation at 37°C. The enriched matrices exhibited significant inhibition against rat intestinal maltase and sucrase with IC50 values of 12.14 and 5.45 mg mL⁻¹, respectively. The described sorption process provided a means to create protein-rich food ingredients containing concentration plant bioactives without excess sugar, fat and water incorporated in a variety of scientifically validated novel food and dietary supplements
Article
Diet is an essential factor affecting the risk for the development and progression of modern day chronic diseases, particularly those with pathophysiological roots in inflammation and oxidative stress-induced damage. The potential impact of certain foods and their bioactive compounds to reverse or prevent destructive dysregulated processes leading to disease has attracted intense research attention. The mango (Mangifera indica Linn.) is a tropical fruit with distinctive nutritional and phytochemical composition. Notably, the mango contains several essential water- and lipid- soluble micronutrients along with the distinguishing phytochemicals gallotannins and mangiferin. In vitro and in vivo studies reveal various mechanisms through which mangos or their associated compounds reduce risk or reverse metabolic- and inflammation- associated diseases. Health benefits of isolated individual mango compounds and extracts from mango by-products are well described in the literature with less attention on the whole fruit. Here, we review and summarize the available literature assessing the health promoting potential of mango flesh, the edible portion contributing to the fruit plate of the diet, focusing specifically on modern day health issues of obesity and the risk factors and diseases it precipitates, including diabetes and cardiovascular disease. Additionally, the review explores new insights on the benefits of mango in brain, skin and intestinal health. Overall, the foundation of research is growing and supporting the potential role for mangos in reducing risk for inflammation- and metabolically- based chronic diseases.
Article
Full-text available
Ethnopharmacological relevance: The prevalence of diabetes is on a steady increase worldwide and it is now identified as one of the main threats to human health in the 21st century. In Nigeria, the use of herbal medicine alone or alongside prescription drugs for its management is quite common. We hereby carry out a review of medicinal plants traditionally used for diabetes management in Nigeria. Based on the available evidence on the species׳ pharmacology and safety, we highlight ways in which their therapeutic potential can be properly harnessed for possible integration into the country׳s healthcare system. Materials and methods: Ethnobotanical information was obtained from a literature search of electronic databases such as Google Scholar, Pubmed and Scopus up to 2013 for publications on medicinal plants used in diabetes management, in which the place of use and/or sample collection was identified as Nigeria. 'Diabetes' and 'Nigeria' were used as keywords for the primary searches; and then 'Plant name - accepted or synonyms', 'Constituents', 'Drug interaction' and/or 'Toxicity' for the secondary searches. Results: The hypoglycemic effect of over a hundred out of the 115 plants reviewed in this paper is backed by preclinical experimental evidence, either in vivo or in vitro. One-third of the plants have been studied for their mechanism of action, while isolation of the bioactive constituent(s) has been accomplished for twenty three plants. Some plants showed specific organ toxicity, mostly nephrotoxic or hepatotoxic, with direct effects on the levels of some liver function enzymes. Twenty eight plants have been identified as in vitro modulators of P-glycoprotein and/or one or more of the cytochrome P450 enzymes, while eleven plants altered the levels of phase 2 metabolic enzymes, chiefly glutathione, with the potential to alter the pharmacokinetics of co-administered drugs. Conclusion: This review, therefore, provides a useful resource to enable a thorough assessment of the profile of plants used in diabetes management so as to ensure a more rational use. By anticipating potential toxicities or possible herb-drug interactions, significant risks which would otherwise represent a burden on the country׳s healthcare system can be avoided.
Article
the 1980's has . . . witnessed a transformation in the approach to diabetes education / new and better strategies were required for the application of Nutritional Principles as well as means for eliciting adherence to these programs / behavioral methods, patient and family participation in the decision-making process, and ministry to patient needs by teams of individuals, each with expertise in an area of health care, have become the accepted norm relate new scientific information on these many and diverse areas to current approaches to nutritional management of the individual with diabetes (PsycINFO Database Record (c) 2012 APA, all rights reserved)
Article
There is controversy regarding the clinical utility of classifying foods according to their glycemic responses by using the glycemic index (GI). Part of the controversy is due to methodologic variables that can markedly affect the interpretation of glycemic responses and the GI values obtained. Recent studies support the clinical utility of the GI. Within limits determined by the expected GI difference and by the day-to-day variation of glycemic responses, the GI predicts the ranking of the glycemic potential of different meals in individual subjects. In long-term trials, low-GI diets result in modest improvements in overall blood glucose control in patients with insulin-dependent and non-insulin-dependent diabetes. Of perhaps greater therapeutic importance is the ability of low-GI diets to reduce insulin secretion and lower blood lipid concentrations in patients with hypertriglyceridemia.
Article
To develop a mathematical model for the determination of total areas under curves from various metabolic studies. In Tai's Model, the total area under a curve is computed by dividing the area under the curve between two designated values on the X-axis (abscissas) into small segments (rectangles and triangles) whose areas can be accurately calculated from their respective geometrical formulas. The total sum of these individual areas thus represents the total area under the curve. Validity of the model is established by comparing total areas obtained from this model to these same areas obtained from graphic method (less than +/- 0.4%). Other formulas widely applied by researchers under- or overestimated total area under a metabolic curve by a great margin. Tai's model proves to be able to 1) determine total area under a curve with precision; 2) calculate area with varied shapes that may or may not intercept on one or both X/Y axes; 3) estimate total area under a curve plotted against varied time intervals (abscissas), whereas other formulas only allow the same time interval; and 4) compare total areas of metabolic curves produced by different studies. The Tai model allows flexibility in experimental conditions, which means, in the case of the glucose-response curve, samples can be taken with differing time intervals and total area under the curve can still be determined with precision.
Article
Diabetes and hypertension will become increasingly common as the population becomes older and more obese. Together, they markedly increase cardiovascular and renal damage, placing all diabetic hypertensives at high risk. Fortunately, the appropriate use of lifestyle changes and multiple drugs will always slow and often stop the progression of this damage.
Hypertension and diabetes Ellenberg & Rifkin's Diabetes Mellitus
  • Nm Kaplan
  • Porte
  • Jr
  • Sherwin
Kaplan NM. Hypertension and diabetes. In: Porte D Jr, Sherwin RS, editors. Ellenberg & Rifkin's Diabetes Mellitus. 5th ed. Stamford Connecticut: Appleton & Large, 1996. p. 1097–1104.